MedPath

To Study the Effect of Krushnajeerakadi yog charvan in Mukhapak w.s.r. to Stomatitis.

Phase 2
Not yet recruiting
Conditions
Recurrent oral aphthae. Ayurveda Condition: MUKHAROGAH,
Registration Number
CTRI/2025/04/084543
Lead Sponsor
Dr Pranali Gajanan Sawarkar
Brief Summary

This study is randomised open control clinical trial to evaluate the efficacy of krushnajeerakadi yog charvan in Mukhapak w.s.r. to stomatitis. Study will be carried in OPD of Shalakyatantra Department at Yashwant Ayurvedic Medical College and hospital Kodoli. The observation will be drawn on the basis of symptoms after treatment given.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patient between the age group 18 to 60 yr, irrespective of gender ,religion ,occupation ,socio-economic status will be selected randomly for the study.
  • Patient having signs & symptoms of mukhapak.
  • Patient having ulcer dimension up to 4mm.
Exclusion Criteria
  • Inflammatory condition of the oral cavity other than stomatitis.
  • Traumatic injury of mouth(eg- Tooth brush, jagged teeth).
  • Known cases of carcinoma on Treatment of Radiotherapy and chemotherapy.
  • Known case of systematic illness with complications which can interfere with the study.
  • Patient having ulcer dimension more than 4mm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reducing the no. of ulcers, pain, burning sensation and redness in oral cavity.3days
Secondary Outcome Measures
NameTimeMethod
Reduction in recurring mouth ulcers along with reducing redness, pain, burning sensation.15 days

Trial Locations

Locations (1)

Yashwant Dharmartha rugnalay Kodoli Dist Kolhapur

🇮🇳

Kolhapur, MAHARASHTRA, India

Yashwant Dharmartha rugnalay Kodoli Dist Kolhapur
🇮🇳Kolhapur, MAHARASHTRA, India
Dr Pranali Gajanan Sawarkar
Principal investigator
7768865860
pranalisawarkar07775@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.